Medios AG (LON:0QB4)

Market Cap	258.22M
Revenue (ttm)	1.56B
Net Income (ttm)	10.38M
Shares Out	n/a
EPS (ttm)	0.42
PE Ratio	24.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,050
Average Volume	3,044
Open	11.48
Previous Close	11.72
Day's Range	11.48 - 11.48
52-Week Range	11.48 - 20.60
Beta	1.24
RSI	45.10
Earnings Date	Mar 28, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, p...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2016
• Employees: 952
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QB4

Financial Performance

In 2024, Medios AG's revenue was 1.88 billion, an increase of 5.51% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.

Financial numbers in EUR